Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A).

Nishida-Fukuda H, Araki R, Shudou M, Okazaki H, Tomono Y, Nakayama H, Fukuda S, Sakaue T, Shirakata Y, Sayama K, Hashimoto K, Detmar M, Higashiyama S, Hirakawa S.

J Biol Chem. 2016 May 13;291(20):10490-500. doi: 10.1074/jbc.M115.683201. Epub 2016 Mar 10.

PMID:
26966180
2.

Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.

Yang JF, Walia A, Huang YH, Han KY, Rosenblatt MI, Azar DT, Chang JH.

Surv Ophthalmol. 2016 May-Jun;61(3):272-96. doi: 10.1016/j.survophthal.2015.12.004. Epub 2015 Dec 17. Review.

PMID:
26706194
3.

Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer.

Lund AW, Medler TR, Leachman SA, Coussens LM.

Cancer Discov. 2016 Jan;6(1):22-35. doi: 10.1158/2159-8290.CD-15-0023. Epub 2015 Nov 9. Review.

4.

Corneal lymphangiogenesis in herpetic stromal keratitis.

Park PJ, Chang M, Garg N, Zhu J, Chang JH, Shukla D.

Surv Ophthalmol. 2015 Jan-Feb;60(1):60-71. doi: 10.1016/j.survophthal.2014.06.001. Epub 2014 Jun 10. Review.

5.

Time-course study of different innate immune mediators produced by UV-irradiated skin: comparative effects of short and daily versus a single harmful UV exposure.

Cela EM, Friedrich A, Paz ML, Vanzulli SI, Leoni J, González Maglio DH.

Immunology. 2015 May;145(1):82-93. doi: 10.1111/imm.12427.

6.

Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Bryant-Hudson K, Conrady CD, Carr DJ.

Prog Retin Eye Res. 2013 Sep;36:281-91. doi: 10.1016/j.preteyeres.2013.06.003. Epub 2013 Jul 19. Review.

7.

Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity.

Sawane M, Kajiya K, Kidoya H, Takagi M, Muramatsu F, Takakura N.

Diabetes. 2013 Jun;62(6):1970-80. doi: 10.2337/db12-0604. Epub 2013 Feb 1.

8.

Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.

Ling S, Li Q, Lin H, Li W, Wang T, Ye H, Yang J, Jia X, Sun Y.

Eye (Lond). 2012 Nov;26(11):1451-8. doi: 10.1038/eye.2012.194. Epub 2012 Sep 14.

9.

Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.

Dellinger MT, Brekken RA.

PLoS One. 2011;6(12):e28947. doi: 10.1371/journal.pone.0028947. Epub 2011 Dec 12.

10.

Malignant melanoma in the elderly: different regional disease and poorer prognosis.

Macdonald JB, Dueck AC, Gray RJ, Wasif N, Swanson DL, Sekulic A, Pockaj BA.

J Cancer. 2011;2:538-43. Epub 2011 Nov 1.

11.

The cutaneous vascular system in chronic skin inflammation.

Huggenberger R, Detmar M.

J Investig Dermatol Symp Proc. 2011 Dec;15(1):24-32. doi: 10.1038/jidsymp.2011.5. Review.

12.

Apelin attenuates UVB-induced edema and inflammation by promoting vessel function.

Sawane M, Kidoya H, Muramatsu F, Takakura N, Kajiya K.

Am J Pathol. 2011 Dec;179(6):2691-7. doi: 10.1016/j.ajpath.2011.08.024. Epub 2011 Oct 6.

13.

Blockade of prolymphangiogenic vascular endothelial growth factor C in dry eye disease.

Goyal S, Chauhan SK, Dana R.

Arch Ophthalmol. 2012 Jan;130(1):84-9. doi: 10.1001/archophthalmol.2011.266. Epub 2011 Sep 12.

14.

Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice.

Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ, Schwarz EM, Xing L.

Arthritis Rheum. 2011 Aug;63(8):2318-28. doi: 10.1002/art.30421.

15.

An important role of lymphatic vessel activation in limiting acute inflammation.

Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M, Werner S, Alitalo K, Detmar M.

Blood. 2011 Apr 28;117(17):4667-78. doi: 10.1182/blood-2010-10-316356. Epub 2011 Mar 1.

16.

Preclinical lymphatic imaging.

Zhang F, Niu G, Lu G, Chen X.

Mol Imaging Biol. 2011 Aug;13(4):599-612. doi: 10.1007/s11307-010-0421-y. Review.

17.

Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.

Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M.

J Exp Med. 2010 Sep 27;207(10):2255-69. doi: 10.1084/jem.20100559. Epub 2010 Sep 13.

18.

Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.

Avraham T, Yan A, Zampell JC, Daluvoy SV, Haimovitz-Friedman A, Cordeiro AP, Mehrara BJ.

Am J Physiol Cell Physiol. 2010 Sep;299(3):C589-605. doi: 10.1152/ajpcell.00535.2009. Epub 2010 Jun 2.

19.

Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.

Jurisic G, Sundberg JP, Bleich A, Leiter EH, Broman KW, Buechler G, Alley L, Vestweber D, Detmar M.

Genes Immun. 2010 Apr;11(3):219-31. doi: 10.1038/gene.2010.4. Epub 2010 Mar 11.

20.

VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Wuest TR, Carr DJ.

J Exp Med. 2010 Jan 18;207(1):101-15. doi: 10.1084/jem.20091385. Epub 2009 Dec 21.

Items per page

Supplemental Content

Write to the Help Desk